Recent Advance in Sensitive Detection of Demethylase FTO
- PMID: 39714929
- DOI: 10.1002/cbic.202400995
Recent Advance in Sensitive Detection of Demethylase FTO
Abstract
Methylation modification is a critical regulatory mechanism in epigenetics and plays a significant role in various biological processes. N6-methyladenosine (m6A) is the most common modification found in RNA. The fat mass and obesity-associated protein (FTO) facilitate the demethylation of m6A in RNA, and its abnormal expression is closely linked to the development of several diseases. As a result, FTO has the potential to serve as an important biomarker for clinical disease diagnosis. Despite its significance, there has been a lack of comprehensive reviews addressing advancements in detection methods for the demethylase FTO. This review provides an overview of the progress in FTO detection methods, ranging from traditional approaches to innovative techniques, with a particular emphasis on recently reported advancements. These novel detection methods can be categorized into strategies based on enzymes, functional nucleic acids (FNA), and conformational changes. We summarize the principles and applications of these detection methods and discuss the current challenges and prospects in this field.
Keywords: FTO; N6-methyladenosine; demethylase; detection; epigenetic modification.
© 2024 Wiley-VCH GmbH.
Similar articles
-
RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.Mol Cancer. 2019 Mar 28;18(1):46. doi: 10.1186/s12943-019-1004-4. Mol Cancer. 2019. PMID: 30922314 Free PMC article.
-
FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.J Exp Clin Cancer Res. 2022 Jan 28;41(1):42. doi: 10.1186/s13046-022-02254-z. J Exp Clin Cancer Res. 2022. PMID: 35090515 Free PMC article.
-
RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells.Biochem Biophys Res Commun. 2020 Sep 10;530(1):235-239. doi: 10.1016/j.bbrc.2020.06.153. Epub 2020 Aug 4. Biochem Biophys Res Commun. 2020. PMID: 32828292
-
FTO: An Emerging Molecular Player in Neuropsychiatric Diseases.Neuroscience. 2019 Oct 15;418:15-24. doi: 10.1016/j.neuroscience.2019.08.021. Epub 2019 Aug 21. Neuroscience. 2019. PMID: 31442565 Review.
-
Oncogenic and Tumor-Suppressive Functions of the RNA Demethylase FTO.Cancer Res. 2022 Jun 15;82(12):2201-2212. doi: 10.1158/0008-5472.CAN-21-3710. Cancer Res. 2022. PMID: 35303057 Review.
Cited by
-
RNA Modification in Metabolism.MedComm (2020). 2025 Mar 10;6(3):e70135. doi: 10.1002/mco2.70135. eCollection 2025 Mar. MedComm (2020). 2025. PMID: 40066222 Free PMC article. Review.
References
-
- I. Orsolic, A. Carrier, M. Esteller, Trends Genet. 2023, 39, 74–88.
-
- V. Parreno, V. Loubiere, B. Schuettengruber, L. Fritsch, C. C. Rawal, M. Erokhin, B. Győrffy, D. Normanno, M. Di Stefano, J. Moreaux, N. L. Butova, I. Chiolo, D. Chetverina, A. M. Martinez, G. Cavalli, Nature 2024, 629, 688–696.
-
- A. K. Classen, Nature 2024, 629, 534–535.
-
- X. Han, J. Guo, Z. Fan, Cell Death Dis. 2021, 12, 598.
-
- G. Cavalli, E. Heard, Nature 2019, 571, 489–499.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials